| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2018 | JNJ Johnson & Johnson | Sneed Michael E | EVP, Global Corp Aff &COO | Sell | 29,000 | $134.80 | $3,909,084.00 | -49.0% | |
| Aug 27, 2018 | ESPR Esperion Therapeutics, Inc. | Newton Roger S | Director | Sell | 17,700 | $51.05 | $903,610.00 | -0.7% | |
| Aug 24, 2018 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Chief Scientific Officer | Sell | 65,000 | $18.39 | $1,195,350.00 | -7.7% | |
| Aug 23, 2018 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $1.29 | $32,250.00 | +6.2% | |
| Aug 23, 2018 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Chief Scientific Officer | Sell | 130,000 | $18.45 | $2,398,500.00 | -7.7% | |
| Aug 23, 2018 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 30,000 | $50.04 | $1,501,100.00 | -20.0% | |
| Aug 23, 2018 | PAHC Phibro Animal Health Corp | Bendheim Jack50 | President And CEO | Sell | 30,000 | $50.04 | $1,501,100.00 | -20.0% | |
| Aug 22, 2018 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 1,667 | $44.48 | $74,148.16 | -13.7% | |
| Aug 21, 2018 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita53 | SVP, Chief Hr Officer | Sell | 50,000 | $23.46 | $1,173,000.00 | -23.1% | |
| Aug 21, 2018 | TXMD Therapeuticsmd, Inc. | Thompson Tommy G51 | Director | Buy | 4,000 | $5.53 | $22,100.00 | +0.6% | |
| Aug 21, 2018 | AMRX Amneal Pharmaceuticals, Inc. | Reasons Bryan M. | CFO | Sell | 11,698 | $23.65 | $276,657.70 | -12.4% | |
| Aug 21, 2018 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 7,893 | $60.02 | $473,709.36 | -15.8% | |
| Aug 20, 2018 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 20,388 | $2.30 | $46,892.40 | -0.8% | |
| Aug 20, 2018 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 5,300 | $3.90 | $20,670.00 | - | |
| Aug 20, 2018 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 195,000 | $105.89 | $20,647,575.00 | -0.2% | |
| Aug 17, 2018 | IRWD Ironwood Pharmaceuticals Inc | Consylman Gina | Chief Financial Officer | Sell | 188 | $18.21 | $3,423.48 | -0.2% | |
| Aug 17, 2018 | ESPR Esperion Therapeutics, Inc. | Newton Roger S | Director | Sell | 7,300 | $50.06 | $365,438.00 | -1.2% | |
| Aug 17, 2018 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 17,508 | $2.10 | $36,766.80 | -0.4% | |
| Aug 16, 2018 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 200,000 | $104.50 | $20,899,800.00 | -0.2% | |
| Aug 16, 2018 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 2,407 | $17.59 | $42,332.87 | -2.7% | |
| Aug 15, 2018 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 33,062 | $47.32 | $1,564,431.94 | -14.5% | |
| Aug 15, 2018 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 151,793 | $103.23 | $15,669,439.60 | -0.1% | |
| Aug 15, 2018 | NVS Novartis AG | Novartis Bioventures Ltd | 10% Owner | Sell | 5,935 | $2.21 | $13,123.25 | -0.1% | |
| Aug 15, 2018 | PAHC Phibro Animal Health Corp | Bendheim Jack50 | President And CEO | Sell | 30,000 | $49.75 | $1,492,600.00 | -20.0% | |
| Aug 15, 2018 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 30,000 | $49.75 | $1,492,600.00 | -20.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.